Oct 12 (Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.


10


Reuters

Latest News

Reuters: Steve Jobs' pre-Apple job application could fetch $50,000 at auction

NewYorkTimes: Why Markets Have Gotten So Jumpy

NewYorkTimes: These Goldfish Are 70 Percent Organic

FOX: Italian campaign promises gloss over grim economic realities

FOX: Trump Jr. to give foreign policy speech in India

Daily Mail: Ivanka Trump arrives at the Winter Olympics in Pyeongchang

FOX: Father slashes son's throat, nearly decapitating 2-year-old: police

FOX: FOX NEWS FIRST: School shooting survivor refuses to stick to CNN 'script'; Trump to speak at CPAC

ABC: Trump Jr. to give foreign policy speech in India

ABC: Eagles center Kelce plays sax with high school jazz band

Daily Mail: Olympics-Ice hockey -Russians top Czechs to reach final

Daily Mail: Turkey summons Dutch diplomat over Armenian "genocide"...

AP: Italian campaign promises gloss over grim economic realities

NewYorkTimes: Comparing Suburbs: Montclair in New Jersey vs. Dobbs Ferry in New York?

CBC: Olympic wake-up call: Day 14 news you might have missed from the Winter Games

AP: Italian campaign promises gloss over grim economic realities

NewYorkTimes: Paperback Row

NewYorkTimes: Is it an Art Collective or a Vietnamese Ad Agency? Yes and Yes.

NewYorkTimes: Essay: Stanley Bing’s Real Identity Was a Closely Guarded Secret. Until It Wasn’t.

NewYorkTimes: Pursuits: Silver-Screen Travel Inspiration for Oscars Season

NewYorkTimes: Children’s Books: In New Novels for Kids, Dangerous Journeys and Hockey Madness

NewYorkTimes: Nonfiction: When It Comes to Writing, Cheston Knapp Is His Own Harshest Critic

NewYorkTimes: Fiction: Ismail Kadare Grapples With the Supernatural